AbbVie EPS - Earnings per Share 2010-2024 | ABBV

AbbVie earnings per share (EPS) for the twelve months ending December 31, 2024 was $2.39, a 12.13% decline year-over-year.

  • AbbVie EPS for the quarter ending December 31, 2024 was $-0.03, a 106.67% decline year-over-year.
  • AbbVie 2024 annual EPS was $2.39, a 12.13% decline from 2023.
  • AbbVie 2023 annual EPS was $2.72, a 58.97% decline from 2022.
  • AbbVie 2022 annual EPS was $6.63, a 2.79% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

AbbVie EPS - Earnings per Share 2010-2024 | ABBV

  • AbbVie EPS for the quarter ending December 31, 2024 was $-0.03, a 106.67% decline year-over-year.
  • AbbVie 2024 annual EPS was $2.39, a 12.13% decline from 2023.
  • AbbVie 2023 annual EPS was $2.72, a 58.97% decline from 2022.
  • AbbVie 2022 annual EPS was $6.63, a 2.79% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B